Table 1.
n = 42 patients | n (%)Median (range) |
---|---|
Age |
58 years (23-81) |
Gender |
|
Male |
19 (45%) |
Female |
23 (55%) |
Performance Status |
|
ECOG 0-2 |
37 (88%) |
ECOG 3-4 |
5 (12%) |
Primary Cancer Diagnosis |
|
Breast |
12 (29%) |
Lung, NSCLC |
10 (24%) |
Melanoma |
9 (21%) |
Head and Neck |
5 (12%) |
Other/Unknown |
6 (14%) |
Intact Brain Metastasis |
20 (48%) |
Resection Cavity |
22 (52%) |
GTR |
11 |
STR |
11 |
Target Volume |
|
GTV/Cavity Maximum Dimension |
3.9 cm (0.8-6.4 cm) |
GTV/Cavity Volume |
13.6 cc (0.2 – 57.0 cc) |
PTV Volume |
24.5 cc (0.8 – 122.0 cc) |
Previous RT and Dose to HR site |
|
None |
20 (48%) |
WBRT |
5 (12%) |
|
37.5 Gy (30-45) |
SRS |
5 (12%) |
|
18 Gy (5-21) |
IMRT |
4 (10%) |
|
47.5 Gy (10-60) |
Combination |
8 (19%) |
|
41.25 Gy (10 -75) |
Time from Previous RT to HR | 13 months (0.3-32.4) |
Abbreviation: NSCLC, non-small cell lung cancer.